Common Genetic Variants in the Myeloperoxidase and Paraoxonase Genes and the Related Cancer Risk: A Review
- 1 October 2012
- journal article
- review article
- Published by Taylor & Francis in Journal of Environmental Science and Health, Part C
- Vol. 30 (4) , 287-322
Abstract
Modern approaches in health care are moving toward the model of “personalized medicine.” Today, current research in molecular biology and medicine is focused on developing genomic markers with predictive, therapeutic, and prognostic significance. One of the most widespread and significant genomic markers is the single nucleotide polymorphism (SNP), which represents a variation in DNA sequence when a single nucleotide differs between members of a biological species or paired chromosomes in an individual. Antioxidant defense enzymes break down dangerous reactive compounds, called reactive oxygen species, and prevent DNA strand from carcinogen-specific mutations. It is well known that inherited variations in genes that encode antioxidant defense enzymes may modulate individual susceptibility to cancer. In our previous study we have determined the predictive significance of several SNPs of superoxide dismutase (SOD) and glutathione peroxidase gene families in the context of cancer risk. The present review includes a summary and discussion of the current findings evaluating the role of SNPs of the myeloperoxidase (MPO) and paraoxanase (PON) genes in cancer occurrence and development. We suggest that rs2333227 (MPO_ -463G/A) and rs854560 polymorphisms have a great predictive significance; they could probably be utilized as cancer predictors in the future. Also, we recommend further in-depth research for rs11079344 (MPO), rs8178406 (MPO), rs2243828 (MPO), rs662 (PON1), rs705379 (PON1), and PON1_304A/G polymorphisms. These SNPs may become significant cancer-associated biomarkers.Keywords
This publication has 103 references indexed in Scilit:
- Xenobiotic-metabolizing gene variants, pesticide use, and the risk of prostate cancerPharmacogenetics and Genomics, 2011
- Genetic Variation in Metabolic Genes, Occupational Solvent Exposure, and Risk of Non-Hodgkin LymphomaAmerican Journal of Epidemiology, 2011
- The MPO -463G>A polymorphism and cancer risk: a meta-analysis based on 43 case-control studiesMutagenesis, 2010
- A Common Mutation in Paraoxonase-2 Results in Impaired Lactonase ActivityJournal of Biological Chemistry, 2009
- Associations of common variants in genes involved in metabolism and response to exogenous chemicals with risk of multiple myelomaCancer Epidemiology, 2009
- Case–control study of oral and oropharyngeal cancer in whites and genetic variation in eight metabolic enzymesHead & Neck, 2008
- Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genesCarcinogenesis, 2008
- A prospective study of genetic polymorphism in MPO, antioxidant status, and breast cancer riskBreast Cancer Research and Treatment, 2008
- Iron intake, oxidative stress-related genes ( MnSOD and MPO ) and prostate cancer risk in CARET cohortCarcinogenesis, 2008
- Free radicals, metals and antioxidants in oxidative stress-induced cancerChemico-Biological Interactions, 2006